ReNetX Bio Employee Directory
Biotechnology ResearchConnecticut, United States2-10 Employees
ReNetX Bio is a small biotechnology company based in New Haven, Connecticut, focused on developing therapies for injuries and damage to the central nervous system. Its flagship program, AXER-204, aims to restore neural connectivity after injury by inhibiting receptors that suppress axon regrowth, with the company progressing toward Phase 2 testing. The work targets conditions such as spinal cord injury, glaucoma, and traumatic brain injury, addressing unmet needs in CNS repair. Its customer frame includes clinicians and researchers seeking new CNS injury treatments for patients, and the company operates within the biotechnology research industry to deliver first-in-class therapeutics. A notable 2020 development was expanding its Scientific Advisory Board with Dr. Kevin Malobisky, reflecting ongoing scientific collaboration.